European drug discovery informatics market is projected to grow at a significant CAGR during the forecast period. The growing research activities such as the implementation of pilot projects related to the Drug Supply Chain Security Act in the region are further supporting the growth of the European drug discovery informatics market. In February 2019, a consortium of various universities including Frankfurt University of Applied Sciences, RheinMain University of Applied Sciences, Fulda University of Applied Sciences, and operational partners including Bayer AG, Boehringer Ingelheim Pharma GmbH & Co. KG, and GEFCO Forwarding Germany GmbH has developed a validated web-based platform called MYTIGATE.
Moreover, the adoption of AI technology by the various pharmaceutical companies for the drug discoveries further offers ample opportunity to the market. For instance, in November 2016, Janssen Pharmaceutical NV partnered with BenevolentAI Ltd. BenevolentAI Ltd. licensed the right to develop, manufacture, and commercialize clinical-stage drug candidates from Janssen after using artificial intelligence to identify untapped potential in Janssen’s portfolio. In May 2018, Roche starts working on drug discovery using AI with Owkin. Therefore, the significant presence of the major pharma companies that are actively engaged in drug discovery along with the adoption of AI analytics solutions in the country is anticipated to drive the growth of the market in Europe.
To Request a Sample of our Report on European Drug Discovery Informatics Market: https://www.omrglobal.com/request-sample/europe-drug-discovery-informatics-market
European Drug Discovery Informatics Market – Segmentation
By Function
- Docking
- Molecular Modeling
- Libraries and Database Preparation
- Sequencing and Target Data Analysis
- Others
By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organization (CRO)
- Others (Research Institutes)
A full Report of European Drug Discovery Informatics Market is Available @ https://www.omrglobal.com/industry-reports/europe-drug-discovery-informatics-market
European Drug Discovery Informatics Market – Segmentation by Geography
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Accenture PLC
- Charles River Laboratories, Inc.
- Cognizant Function Solutions Corp.
- Domainex
- Dassault Systèmes SE
- Eurofins GSC Lux SARL
- Evotec SE
- Infosys Ltd.
- IBM Corp.
- Selvita S.A.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-drug-discovery-informatics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
